UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): ~~March~~May 223, 2019 (May 1, 2019)

E. I. du Pont de Nemours and Company

(Exact Name of Registrant as Specified in Its Charter)



Delaware	1-815	51-0014090
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
Of Incorporation)	File Number)	Identification No.)

974 Centre Road

Wilmington, Delaware 19805

(Address of principal executive offices)

Registrant’s telephone number, including area code: (302) 774-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

~~Item~~Securities ~~8.01. Other~~registered ~~Events~~pursuant to Section 12(b) of the Act:

On March 22, 2019, E. I. du Pont de Nemours and Company issued notices of redemption in full of all of the outstanding (i) $474,152,000 aggregate principal amount of 4.625% Notes due January 15, 2020 (CUSIP No. 263534BZ1), (ii) $295,793,000 aggregate principal amount of 3.625% Notes due January 15, 2021 (CUSIP No. 263534CB3), (iii) $162,621,000 aggregate principal amount of 4.250% Notes due April 1, 2021 (CUSIP No. 263534CE7), (iv) $381,351,000 aggregate principal amount of 2.800% Notes due 2023 (CUSIP No. 263534CK3), (v) $56,839,000 aggregate principal amount of 6.500% Debentures due 2028 (CUSIP No. 263534BG3), (vi) $42,231,000 aggregate principal amount of 5.600% Notes due December 15, 2036 (CUSIP No. 263534BR9), (vii) $48,041,000 aggregate principal amount of 4.900% Notes due January 15, 2041 (CUSIP No. 263534CC1) and (viii) $68,683,000 aggregate principal amount of 4.150% Notes due 2043 (CUSIP No. 263534CJ6) (collectively, the “Notes”).



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
$3.50 Series Preferred Stock	DDPrA	New York Stock Exchange
$4.50 Series Preferred Stock	DDPrB	New York Stock Exchange

~~The Notes will be redeemed on April 22, 2019 at make-whole redemption prices set forth in the respective Notes~~Item 2. On and after the date of redemption, the Notes will no longer be deemed outstanding, interest on the Notes will cease to accrue and all rights of the holders of the Notes will terminate, except for the right to receive the redemption payment upon surrender of the Notes01. Completion ~~The notices~~ of ~~redemption~~Acquisition ~~specifying the terms, conditions and procedures for the respective redemptions are available through the Depository Trust Company~~ or ~~Deutsche~~Disposition Bank Trust Company Americas, c/o Deutsche Bank National Trust Company, 100 Plaza One, 8th Floor, MS 03-0801, Jersey City, NJ 07311-3901, as paying agent for the Notes. The foregoing does not constitute a notice of ~~redemption for the Notes~~Assets.

Effective as of April 1, 2019, in connection with DowDuPont Inc.’s (“DowDuPont”) previously announced intended separation into three independent, publicly traded companies, one for each of its agriculture, materials science and specialty products businesses (the “Intended Business Separations”), DowDuPont entered into a Separation and Distribution Agreement (the “Separation Agreement”) with Dow Inc. (“Dow”) and Corteva Inc., a wholly owned subsidiary of DowDuPont (“Corteva”), that sets forth, among other things, the principal transactions necessary to effect the separations of Dow and Corteva.

On May 1, 2019, in connection with the Intended Business Separations and pursuant to the Separation Agreement, E. I. du Pont de Nemours and Company (“Historical DuPont”) and/or one or more of its subsidiaries completed a series of internal reorganization transactions resulting in the disposition of the legal entities previously owned by Historical DuPont or one of its subsidiaries and associated with DowDuPont’s specialty products business to DowDuPont (the “Historical DuPont SpecCo Disposition”).

On May 2, 2019, in connection with the Intended Business Separations and pursuant to the Separation Agreement, Historical DuPont acquired the legal entities associated with DowDuPont’s agriculture business that were not previously owned by Historical DuPont (i.e., the Dow AgroSciences business) (the “DAS Acquisition”).

Historical DuPont has attached as Exhibits 99.1 and 99.2 hereto the financial statements and pro forma financial information required to be filed pursuant to Rule 3-05 of Regulation S-X and Article 11 of Regulation S-X.

A description of the internal reorganization and related transactions undertaken in connection with the Intended Business Separations can be found in the section entitled “Internal Reorganization” in the information statement (the “Information Statement”) filed as Exhibit 99.1 to Amendment No. 3 to the Registration Statement on Form 10, filed by Corteva with the Securities and Exchange Commission on April 16, 2019 (File No. 001-38710), as such may be amended from time to time.

Item 9.01. Financial Statements and Exhibits.

(b) Pro Forma Financial Information.

Unaudited pro forma combined financial information giving effect to the Historical DuPont SpecCo Disposition and the DAS Acquisition (as well as the disposition by Historical DuPont of its ethylene and ethylene copolymers business, other than its ethylene acrylic elastomers business, to DowDuPont, in order to conform with the presentation of the unaudited pro forma combined financial information included in the Information Statement) is filed herewith as Exhibit 99.1. Additionally, the audited combined financial statements of the Dow AgroSciences business as of December 31, 2018 and 2017 and for the three years ended December 31, 2018, 2017 and 2016 are filed herewith as Exhibit 99.2.

(d) Exhibits.



Exhibit Number		Exhibit Description

23.1		Consent of Deloitte & Touche LLP, Independent Registered Public Accounting Firm.

99.1		Unaudited pro forma combined financial information of E. I. du Pont de Nemours and Company.

99.2		The Audited Combined Financial Statements of The Dow Agricultural Sciences Business as of December 31, 2018 and 2017 for the three years ended December 2018, 2017 and 2016.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~Registrant~~registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

E. I. DU PONT DE NEMOURS AND COMPANY (Registrant) /s/ Jeanmarie F. Desmond Jeanmarie F. Desmond Vice President and Controller



May 3, 2019	E. I. DU PONT DE NEMOURS AND COMPANY
	(Registrant)


	/s/ Gregory R. Friedman
	Gregory R. Friedman
	Vice President and Chief Financial Officer (As Duly Authorized Officer and Principal Financial Officer)

March 22, 2019

Filing Compare · EIDP, Inc.